LEADER 01365nam  2200361   450 
001 9910704426503321
005 20140516153845.0
035   $a(CKB)5470000002441432
035   $a(OCoLC)879889968
035   $a(EXLCZ)995470000002441432
100   $a20140516d2012      ua             0
101 0 $aeng
135   $aurbn||||a||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aTB elimination$iTreatment of drug-susceptible TB disease in persons infected with HIV
210  1$a[Atlanta, Ga.] :$cNational Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of Tuberculosis Elimination,$d[2012]
215   $a1 online resource (1 page)
300   $aTitle from title screen (viewed on May 16, 2014).
300   $a"May 2012."
517 3 $aTreatment of drug-susceptible TB disease in persons infected with HIV
606   $aTuberculosis$xChemotherapy
606   $aHIV-positive persons$xDiseases$xChemotherapy
615  0$aTuberculosis$xChemotherapy.
615  0$aHIV-positive persons$xDiseases$xChemotherapy.
712 02$aNational Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.).$bDivision of Tuberculosis Elimination,
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910704426503321
996   $aTB elimination$93440703
997   $aUNINA